TruSight Oncology portfolio enables clinical research and in-vitro diagnostic CGP solutions ...

The poster presentation details are as follows: Session Name: 616. Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Poster II Publication Number: 2881 Title: MP0533 (CD33 x ...

- Initial data from the ongoing Phase 1b study evaluating R289, a dual IRAK1/4 inhibitor, in LR-MDS Initial data from the dose escalation phase using a July 15, 2024 data cutoff date indicate that ...

These customizable PowerPoint templates are available in the following sizes only ... but do not stretch or modify the master brand mark or crest within the template. Print your poster on campus. For ...

All Environmental Studies majors participate in public poster presentations as part of the thesis process. A poster session is organized for Wednesday in the last week of the fall and winter semesters ...

SOTIO Biotech (SOTIO) is shaping the future of targeted cancer therapies by translating compelling science into patient benefit. The SOTIO pipeline includes three clinical-stage programs: SOT102 ...

Presentations include: Links to all posters and presentations can be found ... results to differ materially from what we expect. Examples of forward-looking statements include, among others ...

today announced that an abstract related to the company’s second generation of proprietary telomere-targeting THIO prodrugs has been accepted for poster presentation during the upcoming 36 th ...